Drawing for THERAPATCH

USPTO serial 90691561

THERAPATCH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KNIEF, MITCHELL IRVIN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with THERAPATCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael A. Geller

Michael A. Geller DLA PIPER LLP (US)P.O. BOX 64807CHICAGO, IL 60664-0807United States

Goods and services

ClassDescriptionStatusFirst use
005biological preparations for use in therapeutics for the treatment of cells, tissues, and organs, namely, to repair and replace cells and tissues, hold grafts, and deliver therapeutic substances, namely, biologics for medical and veterinary use, small molecules for medical and veterinary use and cell-based therapeutics for medical and veterinary use, to cells and tissues in therapeutic need of said substances; biological matrix scaffolds and biological implantable scaffolds for application of biological preparations and biological and biocompatible patchesACTIVE—
010Medical devices, namely, matrix scaffolds and implantable scaffolds made of artificial materials for application of biological preparations and biological or biocompatible patches; Medical Devices, namely, natural, non-living matrix scaffolds and implantable scaffolds for application of biological preparations and biological or biocompatible patchesACTIVE—
042medical research and design services in the field of biological preparations for use in therapeuticsACTIVE—
044medical procedures, namely, application and use of matrix scaffolds and implantable scaffolds for application of biological preparations and biological or biocompatible patches for the treatment of cells, tissues, and organsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 15, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 15, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 8, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 8, 2024EX5GSOU EXTENSION 5 GRANTED—
Oct 8, 2024EXT5SOU EXTENSION 5 FILED—
Oct 8, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 12, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 11, 2024EX4GSOU EXTENSION 4 GRANTED—
Apr 11, 2024EXT4SOU EXTENSION 4 FILED—
Apr 11, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 6, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 4, 2023EX3GSOU EXTENSION 3 GRANTED—
Oct 4, 2023EXT3SOU EXTENSION 3 FILED—
Oct 4, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 12, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 10, 2023EX2GSOU EXTENSION 2 GRANTED—
Apr 10, 2023EXT2SOU EXTENSION 2 FILED—
Apr 10, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 13, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 11, 2022EX1GSOU EXTENSION 1 GRANTED—
Oct 11, 2022EXT1SOU EXTENSION 1 FILED—
Oct 11, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 26, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 1, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 1, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 9, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 21, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 21, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Jan 21, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 21, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 21, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 7, 2022DOCKASSIGNED TO EXAMINER—
Aug 6, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 8, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance